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ABSTRACT
Marek’s disease is one of the greatest problems in poultry production today and vaccination is one of the 
most important ways of prevention. An innvoative method of vaccine delivery by means of nebulisation was 
used for vaccination of newly hatched chicks using HVT FC 126 and its impact on blood cell count (WBC, 
RBC and differential cell count) and H/L ratio was measured. The trial was performed from day 1 to day 21 
of life of newly hatched male chicks. Standard blood cell count was performed in a Neubauer hemocytometer, 
and differential cell count on blood smears stained with MayGrünwald-Giemsa. Blood for that purpose was 
taken from the jugular vein. The results show a signiﬁ cantly higher WBC count in the group vaccinated by 
means of nebulisation than in the non-vaccinated groups on day 5 of the trial, and from the group that received 
only physiological solution, on day 14. In the RBC count there were ﬂ uctuations but without any signiﬁ cant 
differences between the groups during the trial. In differential blood cell count, there were some signiﬁ cant 
differences on days 7 and 21 of the trial, but no differences in H/L ratio. These results show that vaccination by 
means of nebulisation signiﬁ cantly inﬂ uenced the blood cell count but all changes were within the physiological 
range. Nebulisation as a method of vaccination could probably improve the immune response to the wild 
Marek’s disease virus, mimicking natural infection via the respiratory system and as a mass form of vaccination 
could be a powerful method for delivery of recombinant HVT vaccine. 
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Introduction
Marek’s disease (MD) is one of the most important contagious viral diseases of 
chickens. Its lymphoprolypherative nature is characterized by pleomorphic lymphocyte 
inﬁ ltration of various tissues, as well as formation of lymphocyte tumors, often together 
with inﬂ ammatory and degenerative changes in neurons (neurolymphomatosis). MD is 
caused by alpha-herpesvirus of the genus Mardivirus, gallid herpesvirus 2, called MD 
herpesvirus 1 (MDV 1), but two herpes viruses, meleagrid herpesvirus 1 (HVT) and MD 
herpesvirus 2 (gallid herpesvirus 3) (MDV 2), are closely related non-pathogenic viruses 
used as speciﬁ c vaccines against the MD (BAATEN et al., 2004). All these viruses infect 
the chicken organism through the respiratory route, and while strictly intracellular, they 
primarily infect lymphatic cells. MDV 1 infects B cells via macrophages, what leads 
to their lyses, and the same happens after activation and infection of T cells. Immune 
response, which is dominantly cellular, forces MDV into its latent phase, with later 
development of CD4+ T-cell lymphomas (SCHAT and XING, 2000).
It is to be expected that infection with these viruses could cause changes in cellular 
subtypes. The results of previous research (OHASHI et al., 2001; MARKOWSKI-
GRIMSRUD and S CHAT, 2002) have shown that infection with MDV’s and HVT causes 
changes in cellular immune response, but none was able to demonstrate changes in 
basic blood cell count and heterophil/lymphocyte (H/L) ratio. Regarding knowledge of 
the molecular basics of MD pathogenesis, it is better known which mechanisms could 
inﬂ uence erythro- and lymphopoiesis (YAMADA et al., 1998; BACHELDER et al., 2002), as 
well as immune response to infectious viruses (KARACA et al., 2004; SARSON et al., 2006; 
ABDUL-CAREEM et al., 2006 and 2008), and in that way also inﬂ uence the number of those 
cells in the blood.
As lungs are the major route of MD virus entry, nebulisation as a method of vaccination 
via the respiratory system was developed for speciﬁ c vaccine delivery (MAZIJA et al., 
1994). HVT is the only virus in this group which can be produced as a freeze dried 
vaccine, and earlier research showed that Marikal® (Veterina d.o.o., Kalinovica, Croatia) 
was one of the vaccines that, because of its water solubility, can be easily used by means 
of nebulisation (MAZIJA et al., 1994). This method, besides the delivery of vaccine to the 
natural place of viral entry, is also less stressful. Earlier research showed that changes 
in cell count, especially in H/L ratio could be used as a measure of stress in chickens 
(GROSS and SIEGEL, 1983; GROSS, 1990; SHINI et al., 2008).
The aim of this research was to examine changes in blood cell count in chickens 
vaccinated as newly-hatched against MD by means of nebulisation, using the HVT FC 
126 strain. Knowing the changes in blood cell count induced by this virus as potential 
carriers of vector vaccines against different virus diseases (e.g. Newcastle disease virus, 
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infectious bronchitis, infectious bursal disease, avian inﬂ uenza etc.) will give new and 
necessary information on the nature of the immunity expected to be developed. 
Materials and methods
Vaccine. For vaccination of newly-hatched chicks a commercial vaccine was used. 
Vaccine Lyomarex® (Merial, France), containing HVT FC 126, was diluted in distilled 
water, two vials with 1000 doses in 40 mL ddH
2
O for nebulisation, and a vial with 1000 
doses in 200 mL ddH
2
O for s/c application, according to the manufacturer and one dose 
was given per chicken. 
Vaccine delivery. Vaccine was applied by means of ultrasonic nebulisation using 
SONOVAC 095 (MAZIJA and ŠTIMAC, 1999; MAZIJA et al., 2009) or by standard s/c route 
to the nape of the neck. Vaccine for nebulisation was diluted whereby around 70 doses 
were present in a 1.5 mL of vaccine solution, which was aerosolized during 60 seconds of 
nebulisation. In the Sonoavc 095 the vaccine solution was treated with ultrasound which 
produces an aerosol with 95 % of particles ranging between 2-5 μm in diameter. During 
the nebulisation chicks were placed in a closed chamber in which the nebulized aerosol is 
delivered in that one dose of vaccine is provided per chicken. 
Chicks and experimental design. Newly-hatched commercial male Lohmann light 
hybrid chicks were used in the experiment. During the trial, 300 chicks were held in 
cages, and water and feed were offered ad libitum. The chicks were separated into four 
groups (A, B, C, D), with 70 chicks per group, which were divided into 8 cages with a 
maximum of 9 chicks per 0.25 m2. Newly-hatched chicks in group A were vaccinated 
by means of nebulisation and exposed for 60 seconds to the HVT vaccine, while group 
B received the same vaccine by parenteral route (s/c) according to the manufacturer’s 
instructions. Group C received a physiological solution by means of nebulisation (60 
seconds exposure), while group D was not treated and served as a negative control. The 
trial was performed over 21 days. Blood samples with heparin anticoagulant were taken 
from the jugular vein and blood smears were also made before vaccination (day 0) and on 
days 3, 5, 7, 10, 14 and 21 of the experiment. 
Blood cell count and differential cell count. The number of white blood cells (WBC), 
as well as red blood cells (RBC) from the collected samples was counted in a Neubauer 
hemocytometer, according to Natt and Herrick (FUDGE, 2000; CRAY and ZAIAS, 2004), 
while differential WBC count was made on the blood smears stained with May-Grünwald-
Giemsa. One hundred white blood cells were counted to determine differential WBC 
count, as well as to calculate the H/L ratio.
Statistical analysis. Data were tested for normality of distribution and analysed 
using the nonparametric Kruskall-Wallis test using Statistica 7.1 (Statsoft, 2005), and 
signiﬁ cant differences (P<0.05) were marked.
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Results
White blood cell count. The WBC count was elevated on day 3 compared to day 0, 
without any signiﬁ cant differences between the groups (Table 1). On day 5 it was still 
rising in all groups, but in group A it rose to the of level 36.28 ± 7.72×109/L, which is 
signiﬁ cantly different only to the non-vaccinated groups C and D. From day 5 to day 7 
WBC count declined to almost the original level before vaccination, without signiﬁ cant 
difference between groups. From day 7 to day 21 WBC count slightly rose in groups B, 
C and D, without signiﬁ cant differences between groups. The same count in group A rose 
signiﬁ cantly on day 14 compared to group C only, and declined slightly on day 21 without 
any signiﬁ cant difference compared to the other groups of chickens in the trial. 
Table 1. White blood cell count in chicken blood during the trial (×109/L)
Groups
Days after vaccination























































Values are expressed as mean value ± SD. Values with a different letter are signiﬁ cantly different (P<0.05) 
between groups on the same day of experiment
Table 2. Red blood cell count in chicken blood during the trial (×1012/L)
Groups
Days after vaccination























































Values are expressed as mean value ± SD
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Red blood cell count. The RBC cout dropped from day 3 to day 5 in all groups 
of chickens during the experiment (Table 2), but without any signiﬁ cance between the 
groups. On day 7 it rose slightly in group A, and declined in group C, and was at a similar 
level to the other two groups. On day 10 the RBC count was elevated to the level of 2.12 
± 0.39×1012/L in group C and to 2.01 ± 0.32×1012/L in group A, without any signiﬁ cant 
difference. It rose again in groups A and D on day 14 to 2.19 ± 0.23×1012/L and 2.16 ± 
0.25×1012/L, respectively, while in group C it slightly declined without any signiﬁ cance. 
The RBC count rose on day 21 in all groups except A, without any signiﬁ cance between 
groups.
Table 3. Relative ( %) count of lymphocytes in chicken blood during the trial
Groups
Days after vaccination























































Values are expressed as mean value ± SD. Values with a different letter are signiﬁ cantly different (P<0.05) 
between groups on the same day of experiment
Table 4. Relative ( %) count of neutrophils in chicken blood during the trial
Groups
Days after vaccination























































Values are expressed as mean value ± SD. Values with a different letter are signiﬁ cantly different (P<0.05) 
between groups on the same day of experiment
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Table 5. Relative ( %) count of monocytes in chicken blood during the trial
Groups
Days after vaccination























































Values are expressed as mean value ± SD
Table 6. H/L ratio in chicken blood during the trial
Groups
Days after vaccination























































Values are expressed as mean value ± SD
Differential blood cell count. The relative lymphocyte count rose gradually until day 
10 with a slight drop in the count on days 14 and 21 in all experimental groups (Table 3). 
A signiﬁ cant difference was found on day 7 between groups A and D, with percentages 
of 74.42 ± 3.95 and 81.25 ± 4.52, respectively, while on day 21 a signiﬁ cant difference 
was found between groups A and B with percentages of 84.50 ± 6.71 and 76.50 ± 3.02, 
respectively. 
In contrast, the relative number of heterophils (Table 4) declined in all experimental 
groups up to day 10 of the trial, with a slight rise on days 14 and 21. A signiﬁ cant difference 
was found between groups A and D on day 7, with percentages of 24.42 ± 3.40 and 18.12 
± 4.29, respectively, and on day 21 between groups A and B, with percentages of 14.00 ± 
6.78 and 22.37 ± 2.77, respectively. 
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During the whole experiment eosinophils and basophils were not detected or were in a 
very low percentage (below 0.5 %) (data not shown), without any signiﬁ cant differences. 
Relative monocyte count (Table 5) was below 1 % throughout the whole experiment, 
with a slight elevation on day 14 in groups C and D compared to groups A and B, but 
without any signiﬁ cant differences between any of these groups.
H/L ratio. During the trial, the H/L ratio declined from 1.97 ± 0.62 to physiological 
values around 0.20 (Table 6), from day 0 to day 21, respectively. There were no signiﬁ cant 
differences between groups during the trial, but slightly higher levels of H/L ratio in 
group B during the last two days of the trial were recorded. 
Discussion
Marek’s disease is one of the most important diseases of modern poultry production. 
The main problem of its control are the very complex viral kinetics and pathogenesis of 
MDV in relation to genetics, stress, age, gender, environment, as well as simultaneous 
infection with other microorganisms, especially immunosuppressant viral infections 
(BAIGENT and DAVISON, 2004). HVT has been used for decades to protect chickens 
against virulent MDV. Today its solitary immunogenic impact against vv+MDV strains is 
signiﬁ cantly reduced, but as non-cell-associated MDV vaccine it could be resurrected in 
the form of a recombinant vaccine. To develop a recombinant vaccine of good quality, it is 
important to determine all the features of the vector virus. The importance is much more 
signiﬁ cant if the vector virus is delivered by respiratory route by means of nebulisation 
(MAZIJA et al., 2009) that mimics a natural infection. One of the ﬁ rst steps is to detect 
blood cell count changes that could give standard levels of response to the vector virus 
after delivery by nebulisation. Changes in blood cell count could be caused by immune 
response as well, because of the complexity of the viral cycle, by viral avoidance and 
weakening of the same. Vaccination is the most signiﬁ cant method of protection and could 
effectively protect chickens against vv+MDV, and thereby improve production as well as 
the welfare of animals. HVT given to broiler chickens improved weight gain, combined 
with lower mortality (BAATEN et al., 2004), which may be explained by its inﬂ uence on 
growth hormones (LIU et al., 2001), enzymatic systems of cell energy delivery (LI et al., 
1998a, 1998b), cytokines (KAISER et al., 2003), expression of genes involved in signal 
transduction and transcription regulation (KARACA et al., 2004; ABDUL-CAREEM et al., 
2008).
In our experiment there were no clinical reactions to the vaccine given by any means 
of delivery (nebulisation or parenteral). Blood cell count (WBC, RBC, differential WBC, 
H/L ratio) showed differences, but they were all within the physiological range. 
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Results showed that WBC count was signiﬁ cantly inﬂ uenced by vaccination, 
especially by nebulisation (Table 1). Values were within physiological range, from 9.00 
to 32.00×109/L (BOUNOUS and STEDMAN, 2000; POLJIČAK-MILAS et al., 2004), with a 
signiﬁ cant increase in group A, vaccinated by means of nebulisation, on days 5 and 14. 
Such results indicate signiﬁ cant activation of immune cells in the group vaccinated by 
means of nebulisation, compared to parenteral vaccination (s/c), and especially to the 
non-vaccinated groups. It is already known that HVT, like MDV, induces activation of 
immune cells, of innate and active immunity (BAATEN et al., 2004), of different intensity, 
depending mainly on genetic resistance. The same inﬂ uence has been conﬁ rmed at the 
molecular level, with changes in expression of cytokines and their receptors, as well as 
other molecules that participate in immune reaction (KARACA et al., 2004; SARSON et al., 
2006; ABDUL-CAREEM et al., 2006, 2008; HAQ et al., 2010b).
RBC count (Table 2) was in the range of 1.3 to 4.5×1012/L, which is within the 
physiological range (BOUNOUS and STEDMAN, 2000; POLJIČAK-MILAS et al., 2007). 
In group A, vaccinated by means of nebulisation, there was a non-signiﬁ cant reduction 
in RBC count on day 5 compared to the other groups, which could be explained by the 
higher activation of immune mechanisms that might slightly slow the erythropoiesis and 
delivery of mature cells to the blood stream. This could also induce elevation of RBC 
in group A up to day 14 and the subsequent reduction up to day 21. Earlier research 
showed that HVT had an impact on factors important for signal transduction into the 
cell (KARACA et al., 2004), such as CXCR4 connected to tyrosine kinase (CHERNOCK et 
al., 2001; PTASZNIK et al., 2002), or transcribing factors, such as Lmo2 (WADMAN et al., 
1997). As already mentioned, these factors have a very important role in haematopoiesis 
and angiogenesis (YAMADA et al., 1998) and cell migration (BACHELDER et al., 2002.), so 
it is possible that HVT, by inﬂ uencing the level of expression of these molecules in the 
cells, indirectly causes the erythropoiesis and delivery of mature cells to the blood stream, 
in synergy with other systems of signalling in and around the cells, such as cytokines 
(HEIDARI et al., 2008; KAISER et al., 2009; HAQ et al., 2011). 
Differential cell count showed signiﬁ cant differences in lymphocyte and heterophil 
cell count between some groups during the trial, while no signiﬁ cant differences were 
detected in monocyte, eosinophil and basophil cell count. On day 7 the drop in the 
lymphocyte cell count in the vaccinated groups is in a way consistent with the transient 
cell drop caused by cytolysis after MDV and HVT infection (ISLAM et al., 2002) which 
could change the relative cell count. The results on day 21 showed a signiﬁ cant difference 
between the vaccinated groups, where the relative lymphocyte number was higher in 
nebulized group A compared to the s/c vaccinated group B, which could be a sporadic 
ﬁ nding, but also the result of different vaccine delivery and stimulation of immune cells 
(HAQ et al., 2010a), which should be elucidated by further research. 
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The H/L ratio shows elevation in group B, vaccinated s/c, on the last two days of 
the experiment, but without any signiﬁ cant statistical difference, compared to the other 
groups (Table 6). The levels measured are around the physiological values for chickens in 
all groups, but because of their juvenile organism, with the cellular and immune systems 
in development, those values vary in the same groups (SHINI et al., 2008), and are not 
standardized. It is known that stress, especially chronic, can be immunosuppressant 
(POLJIČAK-MILAS et al., 2004), adapting the organism to new conditions, and by metabolic 
changes can even lower weight gain (PUVADOLPIROD and THAXTON, 2000; POST et al., 
2003). In the case of infection (including response to vaccine) it could be characterized 
as a prolonged insult, with probably different pathways between microbiological and 
environmental insult (SHINI et al., 2008). On the other hand, the act of vaccination 
(application) is characterized as acute stress, which according to DHABHAR (2002), could 
have an immune-enhancing effect. In our case, because of the probably mixed stressors 
and juvenile system, H/L ratio results could not be compared to other research results. 
In conclusion, vaccination by means of nebulisation induced signiﬁ cant changes in 
the WBC count in chicken blood, compared to the control groups, in that way inducing 
a signiﬁ cant immune response. On the other hand, it also slightly changed the RBC 
count, but probably as a regular response to such an immunogen, and like the WBC 
and differential WBC count, it remained within the physiological range. The H/L ratio, 
because of the numerous inﬂ uences on it, could not be used as a credible result, but may 
show that nebulisation, as well as infection with vaccinal HVT, is not a stressful insult. 
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SAŽETAK
Marekova bolest predstavlja jedan od najvećih problema u uzgoju peradi pri čemu je cijepljenje jedan 
od najvažnijih postupaka suzbijanja. Korišten je novi postupak primjene cjepiva od soja FC 126 herpesvirusa 
purana jednodnevnim pilićima postupkom nebulizacije pri čemu je analiziran njegov utjecaj na broj stanica u 
krvi (broj leukocita, broj eritrocita i diferencijalnu krvnu sliku) kao i omjer neutroﬁ la i limfocita (N/L). Pokus 
je proveden na jednodnevnim muškim pilićima od prvog do 21. dana života. Korišten je standardni postupak 
brojenja krvih stanica u Neubauerovoj komorici, dok je DKS načinjen na razmazima pune krvi obojene May-
Grünwald-Giemsom. Krv za navedene postupke uzeta je iz jugularne vene. Rezultati pokazuju značajan porast 
broja leukocita u krvi kod skupine cijepljene postupkom nebulizacije u odnosu na necijepljene skupine petog 
dana pokusa, dok od skupine koja je primila samo ﬁ ziološku otopinu ima značajno više leukocita 14. dana 
pokusa. Broj eritrocita pokazuje varijacije u pokusnih skupina, ali bez značajnih razlika tijekom čitavog pokusa. 
Značajne razlike u diferencijalnoj krvnoj slici bile su ustanovljene 7. i 21. dana pokusa, dok kod N/L omjera nije 
bilo značajnih razlika. Navedeni rezultati pokazuju da je cijepljenje postupkom nebulizacije značajno utjecalo 
na broj krvnih stanica te moguće potaknulo speciﬁ čan imunosni odgovor, ali su sve promjene bile u ﬁ ziološkom 
rasponu. Nebulizacija kao postupak primjene cjepiva, iz navedenog, pretpostavlja se može poboljšati imunosni 
odgovor na virus Marekove bolesti oponašajući prirodan način zaražavanja putem dišnog sustava, a može biti 
izvrstan u masovnoj primjeni rekombinantnih cjepiva pripravljenih od herpesvirusa purana.
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